RWAMPARA, Congo -- More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country.
Arkansas Democrat-Gazette's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
RWAMPARA, Congo — More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country.
RWAMPARA, Congo -- More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a critical step to try to fight the deadliest outbreak of the disease in the Central African country.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
